CLINICAL_TRIALS
trial_result
· 2016-07-21
Clinical Trial Update: A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis. [Phase 3]
Summary
A Phase 3 trial evaluating tocilizumab in combination with DMARDs in active rheumatoid arthritis has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-07-21